Role and New Insights of Pirfenidone in Fibrotic Diseases

Pirfenidone (PFD) is a non-peptide synthetic molecule issued as a broad-spectrum anti-fibrotic drug with the ability to decrease TGF-β1, TNF-α, PDGF and COL1A1 expression, which is highly related to prevent or remove excessive deposition of scar tissue in several organs. Basic and clinical evidence...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Med Sci
Autors principals: Lopez-de la Mora, David Alejandro, Sanchez-Roque, Cibeles, Montoya-Buelna, Margarita, Sanchez-Enriquez, Sergio, Lucano-Landeros, Silvia, Macias-Barragan, Jose, Armendariz-Borunda, Juan
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2015
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4643073/
https://ncbi.nlm.nih.gov/pubmed/26640402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.11579
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars